How are we doing in pharma? Do we need to move towards something like rules of origin in trade in drugs? Curious review. Thanks. Sure. Thanks, Dave. First of all, Part of the president's entire trade program is about securing supply chains for critical products. It's not just automotive, it's not just metals, it's not just rare earths, semiconductors, and it's pharmaceuticals. So in the near term, the administration has been quite successful in generating investment in the United States, particularly with branded. (28:34–28:40)
CLAIM
Asserts that securing supply chains for critical products is a key part of the president's trade program.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
